Patent ID: 7625899

Claim:
A Compound of the formula (I), wherein R 1 , R 2 which may be identical or different denote hydrogen or a group selected from among C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl and C 2 -C 6 -alkynyl, wherein each group may be optionally substituted by fluorine, or R 1 and R 2 together denote a 2- to 5-membered alkyl bridge, R 3 denotes hydrogen or a group selected from among C 1 -C 12 -alkyl optionally substituted by fluorine, C 2 -C 12 -alkenyl optionally substituted by fluorine, C 2 -C 12 -alkynyl optionally substituted by fluorine and C 6 -C 14 -aryl optionally substituted by one or more groups selected from OH, NO 2 , CN, OMe, —OCHF 2 , —OCF 3 , —NH 2 , halogen and C 1 -C 10 -alkyl, or a group selected from among C 3 -C 12 -cycloalkyl optionally substituted by one or more groups selected from OH, NO 2 , CN, OMe, —OCHF 2 , —OCF 3 , —NH 2 , halogen, C 1 -C 10 -alkyl, —O—C 1 -C 3 -alkyl, —COOH, —COO—C 1 -C 4 -alkyl and —CONH 2 , C 3 -C 12 -cycloalkenyl, C 7 -C 12 -polycycloalkyl, C 7 -C 12 -polycycloalkenyl and C 5 -C 12 -spirocycloalkyl, R 4 denotes a group selected from among hydrogen, hydroxy and halogen, or a group selected from among C 1 -C 3 -alkyl optionally substituted by fluorine, C 2 -C 6 -alkenyl optionally substituted by fluorine, C 2 -C 6 -alkynyl optionally substituted by fluorine, C 1 -C 5 -alkyloxy, C 2 -C 5 -alkenyloxy and C 2 -C 5 -alkynyloxy, L denotes a linker selected from among C 2 -C 10 -alkyl optionally substituted by fluorine, C 2 -C 10 -alkenyl optionally substituted by fluorine, C 6 -C 14 -aryl optionally substituted by one or more groups selected from OH, NO 2 , CN, OMe, —OCHF 2 , —OCF 3 , —NH 2 , halogen and C 1 -C 10 -alkyl, —C 1 -C 4 -alkyl-C 6 -C 14 -aryl, C 6 -C 14 -heteroaryl wherein up to two C atoms are replaced by one or two nitrogen atoms, while these heteroaryl rings may optionally be anellated to a benzene ring and may optionally carry one or more substituents selected from F, Cl, Br, OH, OMe, methyl, ethyl, CN, CONH 2 , NH 2 , phenyl, pyridyl, and C 3 -C 12 -cycloalkyl optionally substituted by one or more groups selected from OH, NO 2 , CN, OMe, —OCHF 2 , —OCF 3 , —NH 2 , halogen, C 1 -C 10 -alkyl, —O—C 1 -C 3 -alkyl, —COOH, —COO—C 1 -C 4 -alkyl and —CONH 2 , n denotes 0 or 1, R 5 denotes a group selected from among hydrogen or C 1 -C 6 -alkyl optionally substituted by fluorine, C 1 -C 6 -alkenyl optionally substituted by fluorine, C 1 -C 6 -alkynyl optionally substituted by fluorine, C 3 -C 12 -cycloalkyl optionally substituted by one or more groups selected from OH, NO 2 , CN, OMe, —OCHF 2 , —OCF 3 , —NH 2 , halogen, C 1 -C 10 -alkyl, —O—C 1 -C 3 -alkyl, —COOH, —COO—C 1 -C 4 -alkyl and —CONH 2 , or a group selected from among pyridyl, morpholinyl, piperidinyl, piperazinyl, piperazinylcarbonyl, pyrrolidinyl, tropenyl, sulphoxomorpholinyl, sulphonylmorpholinyl, thiomorpholinyl and azacycloheptyl, optionally in the form of the tautomer, the racemate, the enantiomer, the diastereomer and the mixture thereof, or a pharmacologically acceptable acid addition salt thereof.